- 20 April 2008
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (12) , 2053-2054
Abstract
SCOPUS: le.jinfo:eu-repo/semantics/publisheKeywords
This publication has 6 references indexed in Scilit:
- Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant TrialJournal of Clinical Oncology, 2007
- Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytesExperimental Cell Research, 2007
- Oxidative stress reversibly inactivates myocardial enzymes during cardiac arrestAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation–contraction coupling and reduces oxidative stress in adult rat cardiomyocytesJournal of Molecular and Cellular Cardiology, 2006
- Herceptin and the Heart — A Molecular Modifier of Cardiac FailureNew England Journal of Medicine, 2006
- Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31Journal of Clinical Oncology, 2005